A 53-year-old man with fever and rapid neurologic deterioration

New England Journal of Medicine

Volumn 340, Issue 2, 1999, Pages 127-135

  Vattanean, T K ^a   De Ux Moore, S M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; DIFFERENTIAL DIAGNOSIS; ENCEPHALOMYELITIS; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUMBAR PUNCTURE; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; VIRUS ENCEPHALITIS;

EID: 0345369371     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199901143400208     Document Type: Article

References (43)

1. Martyn C. The epidemiology of multiple sclerosis. In: Matthews WB, ed. McAlpine's multiple sclerosis. 2nd ed. New York: Churchill Livingstone, 1991:139-63.
2. Schilder P. Zur Kenntnis der sogenannten diffusen Sklerosen: (Ueber Encephalitis periaxialis diffusa). Z Gesamte Neurol Psychiatr 1912;10:1-60.
3. Poser CM. Diffuse-disseminated sclerosis in the adult. J Neuropathol Exp Neurol 1957;16:61-78.
4. Courville CB. Concentric sclerosis. In: Vinken PJ, Bruyn GW, eds. Multiple sclerosis and other demyelinating diseases. Vol. 9 of Handbook of clinical neurology. Amsterdam: North-Holland Publishing, 1970:437-51.
5. Richardson EP Jr. Progressive multifocal leukoencephalopathy 30 years later. N Engl J Med 1988;318:315-7.
6. Matthews WB. Differential diagnosis. In: Matthews WB, ed. McAlpine's multiple sclerosis. 2nd ed. New York: Churchill Livingstone, 1991:165-88.
7. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10:153-87.
8. Natowicz MR, Bejjani B. Genetic disorders that masquerade as multiple sclerosis. Am J Med Genet 1994;49:149-69.
9. Russell DS. The nosological unity of acute haemorrhagic leucoencephalitis and acute disseminated encephalomyelitis. Brain 1955;78:369-76.
10. Byers RK. Acute hemorrhagic leukoencephalitis: report of three cases and review of the literature. Pediatrics 1975;56:727-35.
11. Poser CM. Disseminated vasculomyelinopathy: a review of the clinical and pathologic reactions of the nervous system in hyperergic diseases. Acta Neurol Scand Suppl 1969;37:3-44.
12. Geerts Y, Dehaene I, Lammens M. Acute hemorrhagic leukoencephalitis. Acta Neurol Belg 1991;91:201-11.
13. Tselis AC, Lisak RP. Acute disseminated encephalomyelitis and isolated central nervous system demyelinative syndromes. Curr Opin Neurol 1995; 8:227-9.
14. Johnson RT. Acute encephalitis. Clin Infect Dis 1996;23:219-24.
15. Fenichel GM. Neurological complications of immunization. Ann Neurol 1982;12:119-28.
16. Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis - clinical and immunologic studies. N Engl J Med 1984;310:137-41.
17. Johnson RT. The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis 1987;155:359-64.
18. Litvak AM, Sands IJ, Gibel H. Encephalitis complicating measles: report of 56 cases with follow-up studies in 32. Am J Dis Child 1943;65:265-95.
19. Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak P. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 1987;316:369-74.
20. Fisher RS, Clark AW, Wolinsky JS, Parhad IM, Moses H, Mardiney MR. Postinfectious leukoencephalitis complicating Mycoplasma pneumoniae infection. Arch Neurol 1983;40:109-13.
21. Shallard B, Latham O. Case of acute haemorrhagic leucoencephalitis. Med J Aust 1945;1:145-8.
22. Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry 1975;38:585-91.
23. Valentine AR, Kendall BE, Harding BN. Computed tomography in acute haemorrhagic leukoencephalitis. Neuroradiology 1982;22:215-9.
24. Watson RT, Ballinger WE Jr, Quisling RG. Acute hemorrhagic leukoencephalitis: diagnosis by computed tomography. Ann Neurol 1984;15:611-2.
25. Hafler DA, Benjamin DS, Burks J, Weiner HL. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis. J Immunol 1987;139:68-72.
26. Davies JM. Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 1997;75:113-26.
27. Rivers TM, Schwentker FF. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 1935;61:689-702.
28. Waksman BH, Adams RD. Studies of the effect of the generalized Shwartzman reaction on the lesions of experimental allergic encephalomyelitis. Am J Pathol 1957;33:155-73.
29. Massacesi GL, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann Neurol 1995;37:519-30.
30. Sobel RA, Blanchette BW, Bhan AK, Colvin RB. The immunopathology of experimental allergic encephalomyelitis. I. Quantitative analysis of inflammatory cells in situ. J Immunol 1984;132:2393-401.
31. Ravkina L, Harib I, Manovitch Z, Deconenko E, Letchinskaja E, Papilova E. Hyperacute experimental allergic encephalomyelitis in rhesus monkeys as a model of acute necrotizing hemorrhagic encephalomyelitis. J Neurol 1979;221:113-25.
32. Levine S, Saltzman A. The hyperacute form of allergic encephalomyelitis produced in rats without the aid of pertussis vaccine. J Neuropathol Exp Neurol 1989;48:255-62.
33. MacMicking JD, Willenborg DO, Weidemann MJ, Rockett KA, Cowden WB. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J Exp Med 1992;176:303-7.
34. Blankenhorn EP, Stranford SA. Genetic factors in demyelinating diseases: genes that control demyelination due to experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalitis virus. Reg Immunol 1992;4:331-43.
35. Laboyrie PM, Wintzen AR, Bots GT. Postinfectious encephalitis in two siblings. Clin Neurol Neurosurg 1991;93:329-33.
36. Vartanian T, Li Y, Zhao M, Stefansson K. Interferon-γ-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1995;1:732-43.
37. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 1996;7:354-70.
38. Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MB. Primary demyelination in transgenic mice expressing interferon-gamma. Nat Med 1997;3:1037-41.
39. D'Souza SD, Bonetti B, Balasingam V, et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996;184:2361-70.
40. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23:339-46.
41. Yonezawa M, Back SA, Gan X, Rosenberg PA, Volpe JJ. Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J Neurochem 1996;67:566-73.
42. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-41.
43. Wren DR, Noble M. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc Natl Acad Sci U S A 1989;86:9025-9.